Skip to main content
KROS logo

KROS · Keros Therapeutics, Inc.

$10.14 -0.07 (-0.69%) At close · Jul 23
Market Cap
$200.69M
Shares
19.79M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2020-03-12 New $56,000,057 $56,000,057
Showing 1–1 of 1 filings
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 18 filings 17 filers Visit website Investor relations